SGF® (Dental Pulp Stem Cell Culture Supernatant) is manufactured at the Ginza Solaria Clinic and affiliated cultivation facility (CPC), a subsidiary of the Solaria Clinic Group.

Since SGF® does not fall under the category of “Specific Cell Processing Products,” there is no requirement for procedures under the “Act on the Safety of Regenerative Medicine and Others.” However, to ensure the safety of production, our clinic’s research laboratory is registered as a “Cell Culture Processing Facility” for the manufacture of “Specific Cell Processing Products.”

Ginza Solaria Clinic: FC3200112

Cultivation Facility (CPC) Owned by Solaria Clinic Group Company: FC3190004

Furthermore, within the research laboratory, individuals holding qualifications as certified clinical culturists recognized by the Japan Society for Regenerative Medicine are involved in the production of SGF®.

※”The structural facilities of the cell culture processing facility must conform to the standards stipulated by the Ministry of Health, Labour and Welfare regulations. (Article 42 of the Act on the Safety of Regenerative Medicine and Others)”